Insulin decreases expression of the proinflammatory receptor proteinase-activated receptor-2 on human airway epithelial cells - 06/09/18
Doi : 10.1016/j.jaci.2018.04.040
Vivek D. Gandhi, MSc a, Nami Shrestha Palikhe, PhD a, Shereen M. Hamza, PhD b, Jason R.B. Dyck, PhD b, Jean Buteau, PhD c, d, Harissios Vliagoftis, MD a 
a Division of Pulmonary Medicine, Department of Medicine, Alberta Respiratory Centre, University of Alberta, Edmonton, Alberta, Canada
b Department of Pediatrics, Cardiovascular Research Centre, University of Alberta, Edmonton, Alberta, Canada
c Alberta Diabetes Institute, Li Ka Shing Centre, University of Alberta, Edmonton, Alberta, Canada
d Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada
| Supported by grants from the Canadian Institutes of Health Research (CIHR) and the Lung Association of Alberta and Northwest Territories (to H.V.) and from CIHR and Diabetes Canada (to J.R.B.D.). V.D.G. received studentships from the Lung Association of Alberta and Northwest Territories and the Respiratory Health Strategic Clinical Network. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 3
P. 1003 - septembre 2018 Retour au numéro
Article précédent
- Paradoxical psoriasis following anti–TNF therapy in ankylosing spondylitis: A population-based cohort study
- Jung Min Bae, Hyuck Sun Kwon, Gyong Moon Kim, Kyung-Su Park, Ki-Jo Kim
- Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial
- Bjorn van Anrooij, Joanne N.G. Oude Elberink, Lambert F.R. Span, Jan G.R. de Monchy, Stefano Rosati, André B. Mulder, Johanna C. Kluin-Nelemans
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?